1. ALLA AKTIER
  2. NYHETER
  3. KDVENTURES

KDventures

Nyheter KDventures Nyheter alla bolag
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

KDventures Annual Report 2025 published

REG

STOCKHOLM, SWEDEN – March 20, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces publication of its Annual Report 2025.

The report is now available to download at www.kd-ventures.com

For further information, please contact:

Viktor Drvota, CEO, KDventures AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota@kd-ventures.com

Hans-Christoffer “HC” Toll, CFO, KDventures AB
Phone: +46 70 717 00 41, e-mail: hc.toll@kd-ventures.com

TO THE EDITORS

About KDventures AB

KDventures AB (Nasdaq Stockholm: KDV) is a Nordic investment company specialized in life sciences. The company identifies and invests in innovative pharmaceutical projects and medical technology products originating from leading research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, KDventures creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with significant value growth potential.

For more information, please visit www.kd-ventures.com

About Us
KDventures AB (Nasdaq Stockholm: KDV) is a Nordic investment company specialized in life sciences. The company identifies and invests in innovative pharmaceutical projects and medical technology products originating from leading research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, KDventures creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with significant value growth potential.
For more information, please visit www.karolinskadevelopment.com.

This information is information that KD Ventures is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-20 08:00 CET.

Attachments
KD AR 2025 (ENG)

Datum 2026-03-20, kl 08:00
Källa MFN
Bifogade filer
KD AR 2025 (ENG)